<DOC>
	<DOCNO>NCT00642850</DOCNO>
	<brief_summary>This single arm study ass efficacy , safety tolerability once-monthly administration intravenous Mircera maintenance hemoglobin level dialysis participant chronic renal anemia . Participants receive monthly intravenous injection Mircera , start dose 120 , 200 360 microgram , accord dose epoetin administer week precede first study drug administration . The anticipated time study treatment 3-12 month , target sample size 100-500 individual .</brief_summary>
	<brief_title>STABIL Study : National Study With Mircera Maintenance Hemoglobin Level Dialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<criteria>Chronic renal anemia ; Continuous stable intravenous maintenance epoetin therapy previous month ; Regular longterm hemodialysis therapy mode dialysis previous 3 month . Transfusion red blood cell previous 2 month ; Poorly control hypertension , , sit blood pressure exceed 170/100 millimeter mercury ( mmHg ) despite medication ; Significant acute chronic bleeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>